Article
Dissection of PIK3CA Aberration for Cervical Adenocarcinoma Outcomes
28 Jun 2021
Abstract excerpt
Personalized treatment of genetically stratified subgroups has the potential to improve outcomes in many malignant tumors. This study distills clinically meaningful prognostic/predictive genomic marker for cervical adenocarcinoma using signature genomic aberrations and single-point nonsynonymous mutation-specific droplet digital PCR (ddPCR). Mutations in PIK3CA E542K, E545K, or H1047R were detected in 41.7% of...
Topics
Join the communities discussing this publication.
